John T. Maxwell
2018
In 2018, John T. Maxwell earned a total compensation of $1.9M as Chief Financial Officer at Aquestive Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $278,964 |
|---|---|
| Option Awards | $382,051 |
| Salary | $360,577 |
| Other | $866,774 |
| Total | $1,888,366 |
Maxwell received $866.8K in other compensation, accounting for 46% of the total pay in 2018.
Maxwell also received $279K in non-equity incentive plan, $382.1K in option awards and $360.6K in salary.
Rankings
In 2018, John T. Maxwell's compensation ranked 6,044th out of 14,244 executives tracked by ExecPay. In other words, Maxwell earned more than 57.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,044 out of 14,244 | 58th |
Division Manufacturing | 2,300 out of 5,765 | 60th |
Major group Chemicals And Allied Products | 860 out of 2,128 | 60th |
Industry group Drugs | 720 out of 1,817 | 60th |
Industry Pharmaceutical Preparations | 560 out of 1,391 | 60th |
Source: SEC filing on April 29, 2020.
Maxwell's colleagues
We found two more compensation records of executives who worked with John T. Maxwell at Aquestive Therapeutics in 2018.